{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:16:47Z","timestamp":1793146607159,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.neurol.2021.06.003","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T09:41:49Z","timestamp":1626342109000},"page":"785-790","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["CGRP and migraine: from bench to bedside"],"prefix":"10.1016","volume":"177","author":[{"given":"L.","family":"Edvinsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2021.06.003_bib0390","series-title":"Cerebri Anatome","author":"Willis","year":"1664"},{"key":"10.1016\/j.neurol.2021.06.003_bib0395","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0031-6997(25)06714-6","article-title":"Amine mechanisms in the cerebral circulation","volume":"28","author":"Edvinsson","year":"1976","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurol.2021.06.003_bib0400","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0006-8993(76)90356-5","article-title":"Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study","volume":"115","author":"Edvinsson","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0405","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.brainresrev.2004.09.007","article-title":"Neurobiology in primary headaches","volume":"48","author":"Edvinsson","year":"2005","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neurol.2021.06.003_bib0410","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0006-8993(76)90951-3","article-title":"Immunohistochemical localization of a vasodilatory polypeptide (VIP) in cerebrovascular nerves","volume":"113","author":"Larsson","year":"1976","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0415","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1021\/ja00822a041","article-title":"Synthesis of the vasoactive intestinal peptide (VIP)","volume":"96","author":"Bodanszky","year":"1974","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.neurol.2021.06.003_bib0420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/265084a0","article-title":"Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds","volume":"265","author":"Said","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2021.06.003_bib0425","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/225863a0","article-title":"Potent peripheral splanchnic vasodilator peptide from normal gut","volume":"225","author":"Said","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2021.06.003_bib0430","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1073\/pnas.80.5.1472","article-title":"Functional role for vasoactive intestinal polypeptide in the caudate nucleus: a 2-deoxy[14C]glucose investigation","volume":"80","author":"McCulloch","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2021.06.003_bib0435","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1113\/jphysiol.1982.sp014142","article-title":"Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses","volume":"325","author":"Edvinsson","year":"1982","journal-title":"J Physiol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0440","first-page":"H449","article-title":"Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide","volume":"238","author":"McCulloch","year":"1980","journal-title":"Am J Physiol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0445","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"97","author":"Goadsby","year":"2017","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurol.2021.06.003_bib0450","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1474-4422(03)00482-4","article-title":"Neuropeptides: opportunities for drug discovery","volume":"2","author":"Hokfelt","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0306-4522(84)90036-8","article-title":"Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat","volume":"11","author":"Everitt","year":"1984","journal-title":"Neuroscience"},{"key":"10.1016\/j.neurol.2021.06.003_bib0460","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0304-3940(83)90003-4","article-title":"Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata","volume":"36","author":"Hokfelt","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2021.06.003_bib0465","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1748-1716.1982.tb07171.x","article-title":"Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function","volume":"116","author":"Lundberg","year":"1982","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neurol.2021.06.003_bib0470","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0166-2236(85)90050-5","article-title":"Functional-role of perivascular peptides in the control of cerebral-circulation","volume":"8","author":"Edvinsson","year":"1985","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neurol.2021.06.003_bib0475","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0304-3940(83)90132-5","article-title":"Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat","volume":"43","author":"Edvinsson","year":"1983","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2021.06.003_bib0480","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1748-1716.1984.tb07493.x","article-title":"Neuropeptide Y: immunocytochemical localization to and effect upon feline pial arteries and veins in vitro and in situ","volume":"122","author":"Edvinsson","year":"1984","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neurol.2021.06.003_bib0485","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.242075","article-title":"Substance p: localization in the central nervous system and in some primary sensory neurons","volume":"190","author":"Hokfelt","year":"1975","journal-title":"Science"},{"key":"10.1016\/j.neurol.2021.06.003_bib0490","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0031-6997(25)06575-5","article-title":"Substance P","volume":"35","author":"Pernow","year":"1983","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neurol.2021.06.003_bib0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0006-8993(78)90146-4","article-title":"Capsaicin-induced depletion of substance P from primary sensory neurones","volume":"152","author":"Jessell","year":"1978","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0500","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1468-2982.1981.0104175.x","article-title":"Adrenergic, cholinergic and peptidergic nerve fibres in dura mater - involvement in headache?","volume":"1","author":"Edvinsson","year":"1981","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0505","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1113\/jphysiol.1981.sp013862","article-title":"Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ","volume":"318","author":"Edvinsson","year":"1981","journal-title":"J Physiol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0510","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1748-1716.1982.tb07159.x","article-title":"Antagonism by (D-Pro2, D-Trp7,9)-substance P of the cerebrovascular dilatation induced by substance P","volume":"116","author":"Edvinsson","year":"1982","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neurol.2021.06.003_bib0515","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/j.1748-1716.1981.tb06771.x","article-title":"Chemical design of antagonists of substance P","volume":"111","author":"Folkers","year":"1981","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neurol.2021.06.003_bib0520","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1748-1716.1981.tb06752.x","article-title":"Inhibition of antidromic and substance P-induced vasodilatation by a substance P antagonist","volume":"111","author":"Rosell","year":"1981","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.neurol.2021.06.003_bib0525","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.6166046","article-title":"Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man","volume":"213","author":"Mayberg","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.neurol.2021.06.003_bib0530","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(83)90402-X","article-title":"Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats","volume":"268","author":"Liu-Chen","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00217397","article-title":"Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater","volume":"234","author":"Edvinsson","year":"1983","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0540","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","article-title":"Pathophysiology of migraine","volume":"75","author":"Pietrobon","year":"2013","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0545","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0550","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2021.06.003_bib0555","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-3940(85)90166-1","article-title":"Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat","volume":"58","author":"Edvinsson","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2021.06.003_bib0560","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0304-3940(85)90296-4","article-title":"Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P","volume":"62","author":"Uddman","year":"1985","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neurol.2021.06.003_bib0565","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0166-2236(85)90050-5","article-title":"Functional role of perivascular peptides in the control of cerebral circulation","volume":"8","author":"Edvinsson","year":"1985","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.neurol.2021.06.003_bib0570","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/jcbfm.1987.126","article-title":"Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects","volume":"7","author":"Edvinsson","year":"1987","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neurol.2021.06.003_bib0575","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ana.410210503","article-title":"Peptide-containing nerve fibers in human cerebral arteries: immunocytochemistry, radioimmunoassay, and in vitro pharmacology","volume":"21","author":"Edvinsson","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(86)90071-6","article-title":"Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects","volume":"15","author":"Uddman","year":"1986","journal-title":"Regul Pept"},{"key":"10.1016\/j.neurol.2021.06.003_bib0585","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0304-3959(86)90162-4","article-title":"Peptide-containing nerve fibres in human extracranial tissue: a morphological basis for neuropeptide involvement in extracranial pain?","volume":"27","author":"Uddman","year":"1986","journal-title":"Pain"},{"key":"10.1016\/j.neurol.2021.06.003_bib0590","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF00225604","article-title":"Axonal tracing of autonomic nerve fibers to the superficial temporal artery in the rat","volume":"256","author":"Uddman","year":"1989","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neurol.2021.06.003_bib0595","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/jcbfm.1989.31","article-title":"Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: colocalization with different peptides","volume":"9","author":"Edvinsson","year":"1989","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neurol.2021.06.003_bib0600","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-1838(89)90109-4","article-title":"Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry","volume":"26","author":"Uddman","year":"1989","journal-title":"J Auton Nerv Syst"},{"key":"10.1016\/j.neurol.2021.06.003_bib0605","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.83.15.5731","article-title":"Calcitonin gene-related peptide: functional role in cerebrovascular regulation","volume":"83","author":"McCulloch","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neurol.2021.06.003_bib0610","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410330109","article-title":"The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats","volume":"33","author":"Goadsby","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0615","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby","year":"1990","journal-title":"Ann Neurol"},{"issue":"Pt 3","key":"10.1016\/j.neurol.2021.06.003_bib0620","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/117.3.427","article-title":"Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies","volume":"117","author":"Goadsby","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2021.06.003_bib0625","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1468-2982.2001.00161.x","article-title":"Lanepitant, an NK-1 antagonist, in migraine prevention","volume":"21","author":"Goldstein","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0630","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1468-2982.1997.1707785.x","article-title":"Ineffectiveness of neurokinin-1 antagonist in acute migraine: a crossover study","volume":"17","author":"Goldstein","year":"1997","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0635","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","article-title":"CGRP antagonists: unravelling the role of CGRP in migraine","volume":"28","author":"Doods","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neurol.2021.06.003_bib0640","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.bjp.0703110","article-title":"Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist","volume":"129","author":"Doods","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0645","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa030505","article-title":"Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine","volume":"350","author":"Olesen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.06.003_bib0650","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(10)60323-6","article-title":"New drugs in migraine treatment and prophylaxis: telcagepant and topiramate","volume":"376","author":"Edvinsson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2021.06.003_bib0655","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0660","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0333102419884943","article-title":"Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries","volume":"40","author":"Rubio-Beltran","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0665","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.25831","article-title":"Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice","volume":"88","author":"Mulder","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0670","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.nurt.2010.02.004","article-title":"CGRP receptor antagonism and migraine","volume":"7","author":"Edvinsson","year":"2010","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neurol.2021.06.003_bib0675","first-page":"633","article-title":"Inhibitory effect of BIBN4096BS","volume":"150","author":"Edvinsson","year":"2007","journal-title":"CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery. Br J Pharmacol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0680","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2007.04.004","article-title":"Effect of two novel CGRP-binding compounds in a closed cranial window rat model","volume":"567","author":"Juhl","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0685","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.0000000000002801","article-title":"TEV-48125 for the preventive treatment of chronic migraine: Efficacy at early time points","volume":"87","author":"Bigal","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2021.06.003_bib0690","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(15)00245-8","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0695","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0333102413517775","article-title":"Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program","volume":"34","author":"Bigal","year":"2014","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0700","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/cs0890565","article-title":"Calcitonin gene-related peptide as an endogenous vasodilator: immunoblockade studies in vivo with an anti-calcitonin gene-related peptide monoclonal antibody and its Fab\u2019 fragment","volume":"89","author":"Tan","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.neurol.2021.06.003_bib0705","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/bjp.2008.334","article-title":"CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat","volume":"155","author":"Zeller","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0710","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/0333102419896760","article-title":"Fluorescently-labeled fremanezumab is distributed to sensory and autonomic ganglia and the dura but not to the brain of rats with uncompromised blood brain barrier","volume":"40","author":"Noseda","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0715","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/head.13105","article-title":"Early Onset of efficacy and consistency of response across multiple migraine attacks from the randomized COMPASS study: AVP-825 Breath Powered((R)) exhalation delivery system (Sumatriptan Nasal Powder) vs oral sumatriptan","volume":"57","author":"Silberstein","year":"2017","journal-title":"Headache"},{"key":"10.1016\/j.neurol.2021.06.003_bib0720","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa1705848","article-title":"A controlled trial of erenumab for episodic migraine","volume":"377","author":"Goadsby","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.06.003_bib0725","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/WNF.0000000000000227","article-title":"Calcitonin gene-related peptide-targeted therapies for migraine and cluster headache: a review","volume":"40","author":"Schuster","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurol.2021.06.003_bib0730","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1177\/0333102419867282","article-title":"Erenumab (AMG 334), a monoclonal antagonist antibody against the canonical CGRP receptor, does not impair vasodilatory or contractile responses to other vasoactive agents in human isolated cranial arteries","volume":"39","author":"Ohlsson","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0735","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s10194-018-0905-8","article-title":"Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries","volume":"19","author":"Ohlsson","year":"2018","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurol.2021.06.003_bib0740","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMra1915327","article-title":"Migraine","volume":"383","author":"Ashina","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2021.06.003_bib0745","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1177\/0333102419854082","article-title":"Long-term safety and tolerability of erenumab: Three-plus year results from a five-year open-label extension study in episodic migraine","volume":"39","author":"Ashina","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neurol.2021.06.003_bib0750","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(19)32504-8","article-title":"Targeting calcitonin gene-related peptide: a new era in migraine therapy","volume":"394","author":"Charles","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2021.06.003_bib0755","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12031-020-01493-z","article-title":"Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion","volume":"70","author":"Edvinsson","year":"2020","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neurol.2021.06.003_bib0760","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/acsptsci.9b00083","article-title":"Molecular mechanisms of class B GPCR activation: insights from adrenomedullin receptors","volume":"3","author":"Garelja","year":"2020","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.neurol.2021.06.003_bib0765","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s10194-020-01197-0","article-title":"Estrogen receptors alpha, beta and GPER in the CNS and trigeminal system - molecular and functional aspects","volume":"21","author":"Warfvinge","year":"2020","journal-title":"J Headache Pain"},{"key":"10.1016\/j.neurol.2021.06.003_bib0770","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1177\/0333102420929027","article-title":"Oxytocin as a regulatory neuropeptide in the trigeminovascular system: Localization, expression and function of oxytocin and oxytocin receptors","volume":"40","author":"Warfvinge","year":"2020","journal-title":"Cephalalgia"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721006068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378721006068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:59Z","timestamp":1758519779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378721006068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":77,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S0035378721006068"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2021.06.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CGRP and migraine: from bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2021.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}